Testing effectiveness (Phase 2)Study completedNCT02589678What this trial is testingZambia SiVET MMR Tdap-IPVWho this might be right forHigh Risk for HIV Emory University 160
Testing effectiveness (Phase 2)Study completedNCT00550589What this trial is testingCidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the AnusWho this might be right forAnal CancerPrecancerous Condition AIDS Malignancy Consortium 33
Not applicableLooking for participantsNCT06242730What this trial is testingDoxycycline PEP and 4CMenB as a Comprehensive Prevention Strategy in MSM and TGW at High Risk for Bacterial STIs Within the Swiss HIV Cohort StudyWho this might be right forDoxycycline STI PEP University of Zurich 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT05122767What this trial is testingRifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS)Who this might be right forTuberculosisHIV The Aurum Institute NPC 92
Large-scale testing (Phase 3)Active Not RecruitingNCT06317051What this trial is testingOptimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)Who this might be right forHIV InfectionsWeight Gain Kirby Institute 300
Not applicableStudy completedNCT05484895What this trial is testingMobile Health Intervention to Increase HIV Testing and Linkage to CareWho this might be right forHIV Emory University 1,800
Early research (Phase 1)Study completedNCT00066430What this trial is testingInfrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal NeoplasiaWho this might be right forAnal CancerPrecancerous Condition AIDS Malignancy Consortium 18
Not applicableStudy completedNCT03226873What this trial is testingPeer Outreach and Navigation Intervention to Increase PrEP Uptake Among Women at High Risk for HIVWho this might be right forPre-exposure ProphylaxisHIV-1-infection Montefiore Medical Center 66
Large-scale testing (Phase 3)Ended earlyNCT04644029What this trial is testingOral ISL QM as PrEP in Cisgender Women at High Risk for HIV-1 Infection (MK-8591-022)Who this might be right forHIV-IHuman Immunodeficiency Virus Type 1Prophylaxis Merck Sharp & Dohme LLC 730
Testing effectiveness (Phase 2)Study completedNCT00000801What this trial is testingPhase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System LymphomaWho this might be right forLymphoma, Non-HodgkinHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 33
Not applicableStudy completedNCT02421159What this trial is testingHybrid STTR Intervention for Heterosexuals: Anonymous Testing and Confidential Care LinkageWho this might be right forHIV/AIDS New York University 500
Not applicableStudy completedNCT00935103What this trial is testingThe Effectiveness of Skill-Based HIV Psychoeducation in IV-Drug Abuser for Reducing High-risk BehaviorWho this might be right forAddictionRisk Reduction Behaviour Iran University of Medical Sciences 120
Not applicableStudy completedNCT06274060What this trial is testingProject Phakama: Testing Support Strategies to Empower Young Women on PrEP in South AfricaWho this might be right forPre-exposure ProphylaxisHIV Infections Johns Hopkins Bloomberg School of Public Health 304
Not applicableStudy completedNCT03553693What this trial is testingRapid HIV Viral Load Monitoring in High Risk Patients In UgandaWho this might be right forHIV University of California, San Francisco 2,443
Not applicableStudy completedNCT01970787What this trial is testingA Trial of Radiofrequency Ablation for Anal Intraepithelial Neoplasia Using the HALO Ablation SystemWho this might be right forHIV-negative Subjects With Intra-anal Intraepithelial Neoplasia Containing High-Grade Squamous Intraepithelial Lesions Medtronic - MITG 22
Large-scale testing (Phase 3)Study completedNCT01607541What this trial is testingPeer-driven Intervention to Seek, Test & Treat Heterosexuals at High Risk for HIVWho this might be right forHIV/AIDS New York University 3,400
Not applicableStudy completedNCT05417620What this trial is testingLe Kip Kip: A Campaign to Change Social Norms and Build Sustainable Demand for PrEP Among Women in South AfricaWho this might be right forPre-exposure ProphylaxisHIV Infections Johns Hopkins Bloomberg School of Public Health 601
Not applicableStudy completedNCT02495779What this trial is testingFeasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIVWho this might be right forHuman Immunodeficiency Virus James Egan 54
Testing effectiveness (Phase 2)Study completedNCT00885703What this trial is testingHigh-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected IndividualsWho this might be right forCryptococcal MeningitisHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 168
Testing effectiveness (Phase 2)Study completedNCT02841774What this trial is testingHigh Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIVWho this might be right forHIV InfectionCoronary Heart Disease Matthew Feinstein 10